Praxis Precision Medicines, Inc.: Baird raises target price to $568 from $514
PRAX•Baird raised its target price for Praxis Precision Medicines, Inc. to $568 from $514.
Related News

Clearwater Paper names Matt Passarello CFO
CLW•

Wells Fargo raises FrontView REIT target price to $22 from $20
FVR•

Zymeworks announces $200 million share repurchase authorization
ZYME•

Easterly Government Properties participates in investor meetings at Nareit's REITworld annual conference
DEA•

Empire Petroleum reports third-quarter 2026 financial results and operational update
EP•